This HTML5 document contains 139 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q51062066
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel מאמר מדעי научни чланак naučni članak artigo científico 2013年学术文章 artykuł naukowy wetenschappelijk artikel tudományos cikk article scientifique επιστημονικό άρθρο vědecký článek บทความทางวิทยาศาสตร์ scientific article published on 29 March 2013 vedecký článok 2013年學術文章 artigo científico 2013 nî lūn-bûn teaduslik artikkel articolo scientifico artikull shkencor artículu científicu 2013年學術文章 tieteellinen artikkeli scientific article published on 29 March 2013 wissenschaftlicher Artikel 2013年學術文章 bài báo khoa học bilimsel makale article científic სამეცნიერო სტატია научна статия 2013년 논문 2013年学术文章 artigo científico article scientific 2013年学术文章 artikel ilmiah 2013年學術文章 مقالة علمية نشرت في 29 مارس 2013 мақолаи илмӣ scientific article published on 29 March 2013 artikulong pang-agham 2013年学术文章 наукова стаття, опублікована в березні 2013 vitenskapelig artikkel videnskabelig artikel 2013年學術文章 2013年学术文章 научная статья articol științific 2013年の論文 artículo científico publicado en 2013 scienca artikolo 2013年学术文章 научни чланак ২৯ মার্চ ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vitskapeleg artikkel
p:P577
wds:Q51062066-1E517688-C0AF-4389-8988-782C77E878F6
wdt:P577
2013-03-29T00:00:00Z
p:P407
wds:Q51062066-7407EDF8-E6C4-4780-94CE-713F1E165A76
wdt:P407
wd:Q1860
p:P2093
wds:Q51062066-A19A51CD-018B-414D-8234-51D3A0C2BE65 wds:Q51062066-A257D372-EF71-4AFB-93D3-71C39C1C4198 wds:Q51062066-9D3ECD54-1DB4-48E1-912C-D80967F5B93B wds:Q51062066-87703B44-EA08-4CAA-AE16-27FC4FE51E9E wds:Q51062066-95CE224C-7F26-4265-9C57-2CB1675C9425 wds:Q51062066-7CD25FC2-ACA2-47DE-AD6D-8AC33C85D476 wds:Q51062066-87181FB8-4D0E-4D05-9FEE-F7395873C49A wds:Q51062066-D6FFA3FE-F2E2-4AF6-89F8-FFC809E86B2A wds:Q51062066-D7203D42-D427-461B-9D0C-AADB6DF5397D wds:Q51062066-C1F96AE5-1633-49C5-A7B4-63C4D2B268C1 wds:Q51062066-CF20B994-E9FA-489A-8B04-22D6630DCB71 wds:Q51062066-DA873EC2-39D8-452E-8280-55829B99C544 wds:Q51062066-DCA0C0F8-2316-4A24-A4AE-30E8AEB775EF wds:Q51062066-08930792-94F9-417A-949D-CF70DD110403 wds:Q51062066-37E54555-6016-441F-8C0E-272DD8EB1D74 wds:Q51062066-3BDF1EAA-9730-4A87-8507-1A6E10EBEE6C wds:Q51062066-261EC279-F8F8-4137-BE01-F7F999F278F1 wds:Q51062066-2F298E8B-05F0-4E3E-B70B-8AC2E89D7019 wds:Q51062066-10E0530A-A7D1-4C6B-84D7-55FA9997A064 wds:Q51062066-1017CBA6-BAF4-4DB3-940B-5D8DE3BFA798 wds:Q51062066-6667F6DB-B689-4FDB-8B59-260D32916477 wds:Q51062066-5A824FFF-4692-41C5-A458-CFD5CD3D38C1 wds:Q51062066-572657E9-8D17-4340-90C2-30D1F6E84566 wds:Q51062066-4BE056B7-D773-43A6-9289-78C9D64FBD6E wds:Q51062066-4FB53A55-A2EB-4DB5-B97D-66E045E79177
wdt:P2093
Katherine Welch Nalini Sadagopan Donald J Skalitzky Sandra Lightle Mark S Plummer Richard Gowan Timothy Braden Christopher Whitehead James Hicks David Beidler Annise Goodman Xiao Kang Lu Aurash Shahripour Cindy Spessard Susan Bove Brian Sanchez Howard Miller Adam Ogden Joseph Cornicelli Craig Banotai Xi Qiang Shen Howard Roark Heidi Baum Ron Sarver Charles J Stankovic
rdfs:label
Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: optimization studies and demonstration of in vivo efficacy. Discovery of potent selective bioavailable phosphodiesterase 2
skos:prefLabel
Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: optimization studies and demonstration of in vivo efficacy. Discovery of potent selective bioavailable phosphodiesterase 2
schema:name
Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: optimization studies and demonstration of in vivo efficacy. Discovery of potent selective bioavailable phosphodiesterase 2
p:P50
wds:Q51062066-0B527D60-7D03-4EC0-9244-EA5714744233
wdt:P50
wd:Q42672744
p:P1476
wds:Q51062066-59EBEA47-C2EA-441F-B0F6-EB91D4A3BD1C
wdt:P1476
Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: optimization studies and demonstration of in vivo efficacy.
p:P304
wds:Q51062066-CF93CCA1-5A93-4C09-B405-28BB03F31DE3
wdt:P304
3443-3447
p:P31
wds:Q51062066-BBA2BEC9-4932-4BEB-9D6C-E0A8B2A2D39C
wdt:P31
wd:Q13442814
p:P698
wds:Q51062066-97406A16-E223-408D-A130-400507DEFE41
wdtn:P698
n11:23597790
wdt:P698
23597790
p:P1433
wds:Q51062066-63D1EFAE-1B54-406E-8D1D-1BFF88E4453F
wdt:P1433
wd:Q2709483
p:P433
wds:Q51062066-E033E8CE-6059-4934-8826-3FAA263439C7
p:P478
wds:Q51062066-D677FA1B-7722-46E3-A754-C70AB48A61E6
wdt:P433
11
wdt:P478
23
p:P356
wds:Q51062066-B795DD5A-34AC-48F7-85A7-6D57284EB0F7
wdtn:P356
n9:J.BMCL.2013.03.082
wdt:P356
10.1016/J.BMCL.2013.03.082